Excipient World 2026: Trends in Drug Delivery & Formulation

Key Takeaways

• Excipient World Conference & Expo 2026 is set to highlight the critical role of pharmaceutical excipients in drug formulation and delivery.
• Clariant will participate, showcasing its portfolio of functional excipients designed for precise drug product manufacturing.
• The conference will address key trends, advances in drug delivery technologies, and the development of novel excipients within the pharmaceutical industry.

The Excipient World Conference & Expo 2026, scheduled for May 2026 in the US, will gather industry experts to discuss the latest advancements and trends in pharmaceutical excipients. This event focuses on the excipient market, covering new delivery methods, novel excipients, and their crucial role in drug formulation.

Excipients, the inactive ingredients in drug products, play a vital role in ensuring drug stability, delivery, and overall effectiveness. As the pharmaceutical industry faces increasing complexity in drug development, the importance of excipients in achieving desired therapeutic outcomes continues to grow.

Excipient World Conference & Expo 2026 Overview

The Excipient World Conference & Expo 2026 is a key event for professionals involved in pharmaceutical formulation and drug delivery. The conference will address the latest trends and advances in the excipient market. Clariant, a leading provider of specialty chemicals, will participate, showcasing its range of functional excipients designed to enhance drug product manufacturing.

While the conference is expected to provide valuable insights into excipient technology, no specific drug data or clinical trial results are anticipated to be presented at this event.

IntelligenceRegulatory Impact▾

FDA are the agencies to watch. Regulatory relevance reads medium for general. Teams should track submission types, designations, and guidance shifts that could move approval timelines.

Excipient Industry Trends

The pharmaceutical industry is currently navigating a period of significant change, driven in part by the impending patent cliff between 2024 and 2030. This period will see the loss of exclusivity (LOE) for many branded drugs, impacting pharmaceutical strategies and supply chains. Companies are advised to closely monitor products based on revenue exposure and LOE dates.

Other factors influencing the pharmaceutical landscape include Orphan Drug Exclusivity (ODE), which provides seven years of market exclusivity for drugs targeting rare diseases (affecting fewer than 200,000 patients in the U.S.), and pediatric exclusivity, which can add an additional six months of market protection.

IntelligenceCompetitive Intelligence▾

Competitive pressure is low. Watch which sponsors move first. Benchmark pipeline positioning, differentiation, and partnership scouting against the signals in this story.

Related Excipient Events

Several other events in 2026 will also focus on excipients and related topics. The IPEC Europe Excipients Forum, held in Torremolinos, Spain, on February 5, 2026, will address sustainability, the evolving regulatory landscape, and the maturation of the excipient industry. Key speakers include Dr. Petra Doerr, Director at EDQM, who will discuss the EDQM's strategic framework, including its sustainability roadmap and the move towards carbon neutrality by 2050.

An expert panel moderated by Adrian Bone, featuring panelists from Lonza, Colorcon, Imerys, P&G, and Novo Nordisk, will discuss the regulatory landscape, audit deficiencies, cross-sector regulations, scrutiny trends, and the overall maturation of the excipient industry.

PBP Prague 2026, scheduled for March 23-26, 2026, in Prague, will cover excipients in the context of physico-chemical principles and manufacturing. The event will feature invited industry speakers, short talks selected from submitted abstracts, and invited talks on the science of excipients.

Frequently Asked Questions

What is the focus of the Excipient World Conference & Expo 2026? The conference focuses on pharmaceutical excipients, their role in drug formulation, and advancements in drug delivery technologies. Which company is participating and showcasing their excipients at the event? Clariant will be participating and showcasing its functional excipients portfolio for precise drug product manufacturing. What are some of the key industry trends affecting the excipient market? Key trends include the patent cliff (2024-2030), loss of exclusivity for branded drugs, orphan drug exclusivity, and pediatric exclusivity. Are there any specific drug data or clinical trial results expected to be presented at the conference? No specific drug data or clinical trial results are expected to be presented at this event. What other related events are taking place in 2026 that focus on excipients? The IPEC Europe Excipients Forum 2026 and PBP Prague 2026 are two other events that will cover excipients and related topics.

References

• IPEC Europe Excipients Forum 2026 Key Takeaways
• PBP Prague 2026 Program
• Clariant at Excipient World Conference & Expo

Related coverage

• Sanofi pipeline pdf: Dupixent, Lantus and 2026 catalysts
• FDA approves Vertex’s Journavx as first non-opioid pain drug for acute pain
• Eli Lilly pipeline and deals: GLP-1, vaccines, and 2026 outlook